Principaux actionnaires
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
September 20, 2024 13:45 ET | ONWARD Medical NV
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par...
ONWARD_Logotype®_Red.png
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
September 19, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
ONWARD_Logotype®_Red.png
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière
September 19, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine pour restaurer le mouvement après une lésion de la moelle épinière
ONWARD_Logotype®_Red.png
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
September 10, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
ONWARD_Logotype®_Red.png
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
September 03, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
ONWARD_Logotype®_Red.png
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
August 27, 2024 12:53 ET | ONWARD Medical NV
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
ONWARD_Logotype®_Red.png
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
August 05, 2024 17:47 ET | ONWARD Medical NV
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
ONWARD_Logotype®_Red.png
ONWARD® Medical Publishes Annual Sustainability Summary
July 17, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Publishes Annual Sustainability Summary
ONWARD_Logotype®_Red.png
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
July 09, 2024 13:18 ET | ONWARD Medical NV
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
ONWARD_Logotype®_Red.png
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
June 28, 2024 17:53 ET | ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty...